Stage IB Non-small Cell Lung Cancer
Also known as: Non-small Cell Lung Cancer Stage IB
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09037 | Pembrolizumab | Programmed cell death protein 1 | target |
| DB09037 | Pembrolizumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00945 | Acetylsalicylic acid | 0 | Terminated | 1 |
| DB00184 | Nicotine | 1 | Completed | 1 |
| DB00530 | Erlotinib | 2 | Terminated | 1 |
| DB11737 | Icotinib | 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB05578 | Ramucirumab | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 3 | Completed | 1 |
| DB00317 | Gefitinib | 3 | Completed | 1 |
| DB01229 | Paclitaxel | 3 | Completed | 1 |